Variant report
Variant | esv2761812 |
---|---|
Chromosome Location | chr13:95639780-95643937 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:2)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:2 , 50 per page) page:
1
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs534735737 | chr13:95639793-95639794 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
2 | rs2209540 | chr13:95639797-95639798 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
3 | rs578049286 | chr13:95639813-95639814 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs537121744 | chr13:95639850-95639851 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs376073307 | chr13:95639865-95639866 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs557544934 | chr13:95639881-95639882 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs369195802 | chr13:95639888-95639889 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs574185562 | chr13:95639933-95639934 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs2225007 | chr13:95639934-95639935 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
10 | rs560130219 | chr13:95639948-95639949 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs2209539 | chr13:95639962-95639963 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
12 | rs148704716 | chr13:95640028-95640029 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs181473191 | chr13:95640033-95640034 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs2209538 | chr13:95640035-95640036 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
15 | rs544012946 | chr13:95640040-95640041 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs561018583 | chr13:95640043-95640044 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs186211960 | chr13:95640071-95640072 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs201572859 | chr13:95640078-95640079 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs199526549 | chr13:95640079-95640080 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs75003604 | chr13:95640081-95640082 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs3046294 | chr13:95640101-95640102 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs117936411 | chr13:95640102-95640103 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
23 | rs373409989 | chr13:95640112-95640113 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
24 | rs546378005 | chr13:95640226-95640227 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
25 | rs111383791 | chr13:95640258-95640259 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
26 | rs114476682 | chr13:95640372-95640373 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
27 | rs142462646 | chr13:95640374-95640375 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
28 | rs571515796 | chr13:95640377-95640378 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
29 | rs151336712 | chr13:95640420-95640421 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
30 | rs531059017 | chr13:95640429-95640430 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
31 | rs557200682 | chr13:95640437-95640438 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
32 | rs78979946 | chr13:95640463-95640464 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
33 | rs369074465 | chr13:95640500-95640501 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
34 | rs140602699 | chr13:95640504-95640505 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
35 | rs1925869 | chr13:95640565-95640566 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
36 | rs145827968 | chr13:95640570-95640571 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
37 | rs563765791 | chr13:95640582-95640583 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
38 | rs559190816 | chr13:95640612-95640613 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
39 | rs575162499 | chr13:95640626-95640627 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
40 | rs61965527 | chr13:95640649-95640650 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
41 | rs79131989 | chr13:95640651-95640652 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
42 | rs544193617 | chr13:95640673-95640674 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
43 | rs200113959 | chr13:95640690-95640691 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
44 | rs560858257 | chr13:95640717-95640718 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
45 | rs146603151 | chr13:95640726-95640727 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
46 | rs181646348 | chr13:95640728-95640729 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
47 | rs559884382 | chr13:95640795-95640796 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
48 | rs549736690 | chr13:95640815-95640816 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
49 | rs1925868 | chr13:95640830-95640831 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
50 | rs552222417 | chr13:95640844-95640845 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
HIV/AIDS | 22032296 | CNVD |
Prostate cancer | 16705090 | CNVD |
High-proliferative meningiomas | 17937814 | CNVD |
Cancer | 20164919 | CNVD |
Autism | 22495311 | CNVD |
Chordoma | 21602918 | CNVD |
Bladder cancer | 21949216 | CNVD |
Acute myeloid leukemia | 16864856 | CNVD |
Burkitt''s lymphoma | 18698080 | CNVD |
Cancer | 21637783 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Chronic lymphocytic leukemia | 21518781 | CNVD |
colon cancer | 17210682 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Colorectal cancer | 20709793 | CNVD |
Astrocytoma | 17387387 | CNVD |
Breast cancer | 21264507 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Ovarian cancer | 20844748 | CNVD |
Colorectal cancer | 19359472 | CNVD |
Intracranial aneurysm | 19064780 | CNVD |
Breast cancer | 19287154 | CNVD |
Acute myeloid leukemia | 18379011 | CNVD |
Human rectal carcinomas | 16397240 | CNVD |
Olfactory neuroblastoma | 18408657 | CNVD |
Multiple myeloma | 17077331 | CNVD |
Ependymoma | 16718352 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
Colorectal cancer | 16272173 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Gastrointestinal stromal cancer | 16982739 | CNVD |
Breast cancer | 16608533 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Ovarian cancer | 22174824 | CNVD |
Myoepithelioma | 18604193 | CNVD |
Breast cancer | 17133270 | CNVD |
Prostate cancer | 18632612 | CNVD |
Melanoma | 18172304 | CNVD |
Prostate cancer | 16573809 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Basal cell lymphoma | 17053054 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
Gastric cancer | 17908304 | CNVD |
Splenic marginal zone lymphoma | 18492102 | CNVD |
Liposarcoma | 21253554 | CNVD |
Acute promyelocytic leukemia | 19109227 | CNVD |
Chronic lymphocytic leukemia | 20421269 | CNVD |
Acute lymphoblastic leukemia | 21980252 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Lung cancer | 18438408 | CNVD |
Non-syndromic sensorineural hearing loss | 20606397 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Esophageal cancer | 21851588 | CNVD |
Omodysplasia | 19481194 | CNVD |
Breast cancer | 22032731 | CNVD |
Rhabdomyosarcoma | 17210683 | CNVD |
Burkitt''s lymphoma | 19759907 | CNVD |
Wilms tumour | 21544195 | CNVD |
Developmental delay | 21147756 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Hirschsprung''s Disease | 21712996 | CNVD |
Cancer | 21183584 | CNVD |
Breast cancer | 17603634 | CNVD |
Non-syndromic sensorineural hearing loss | 15273396 | CNVD |
Thyroid cancer | 19087340 | CNVD |
abortions and stillbirths | 19751515 | CNVD |
low-grade B-cell lymphoma tumor | 18367492 | CNVD |
Acute myeloid leukemia | 21251322 | CNVD |
Acute myeloid leukemia | 19651601 | CNVD |
Congenital anomalies of the kidney and urinary tract | 20467480 | CNVD |
Esophageal adenocarcinoma | 18820669 | CNVD |
Breast cancer | 22522925 | CNVD |
Pancreatic cancer | 17952125 | CNVD |
Intellectual disability | 22102821 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr13:95637600-95640800 | Weak transcription | HUES48 Cell Line | embryonic stem cell |
2 | chr13:95637600-95640800 | Weak transcription | iPS-15b Cell Line | embryonic stem cell |
3 | chr13:95637600-95645200 | Weak transcription | HUES6 Cell Line | embryonic stem cell |
4 | chr13:95638000-95644800 | Weak transcription | ES-I3 Cell Line | embryonic stem cell |
5 | chr13:95639400-95641000 | Enhancers | Stomach Mucosa | stomach |
6 | chr13:95640800-95641000 | Enhancers | iPS-20b Cell Line | embryonic stem cell |
7 | chr13:95640800-95641400 | Enhancers | HUES48 Cell Line | embryonic stem cell |
8 | chr13:95640800-95641400 | Enhancers | iPS-15b Cell Line | embryonic stem cell |
9 | chr13:95641000-95644400 | Weak transcription | iPS-20b Cell Line | embryonic stem cell |
10 | chr13:95641400-95644600 | Weak transcription | HUES48 Cell Line | embryonic stem cell |
11 | chr13:95641400-95646600 | Weak transcription | iPS-15b Cell Line | embryonic stem cell |
12 | chr13:95643800-95647600 | Enhancers | H9 Derived Neuron Cultured Cells | ES cell derived |